These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5702858)

  • 1. [Effect of Atromid S on lipid metabolism in coronary insufficiency].
    Gabryś B; Konturek S; Keita-Fyda A
    Pol Tyg Lek; 1968 Oct; 23(42):1608-10. PubMed ID: 5702858
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)].
    Sobra J; Heyrovský A; Sulc M; Horáková D
    Cas Lek Cesk; 1969 Aug; 108(36):1065-9. PubMed ID: 5807234
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T
    Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V; Schneiderman B; Finatti AA; Netto RF
    Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772
    [No Abstract]   [Full Text] [Related]  

  • 8. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of ethyl-chlorphenoxy-isobutyrate on serum lipid values in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diezendy S; Erdélyi G
    Orv Hetil; 1966 May; 107(22):1020-2. PubMed ID: 5935787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipid metabolism indices in patients with chronic ischemic heart disease and psychopathologic syndromes].
    Lazarev VI; Beliakova NA
    Vrach Delo; 1983 Oct; (10):12-5. PubMed ID: 6359687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid and protein components of plasma lipoproteins in coronary arteriosclerosis].
    Gasilin VS; Kurdanov KhA; Torkhovskaia TI; Perova NV; Polesskiĭ VA
    Sov Med; 1981; (7):7-11. PubMed ID: 7292126
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the complex method of Il'k, Dodik and Iovanovich for diagnosis of humoral lipid disorders in coronary atherosclerosis].
    Fomina LF; Sulava SG; Sulava PV
    Ter Arkh; 1968 Jun; 40(6):61-3. PubMed ID: 5739211
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum lipids and lipoproteins in control subjects and patients with ischaemic heart disease.
    Barrington H; Abraham KA; Hill PG; Kanagasabapathy AS; Cherian G
    J Assoc Physicians India; 1980 Aug; 28(8):217-22. PubMed ID: 7462125
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with the coronary drug carduben].
    Thönelt K
    Z Allgemeinmed; 1970 Nov; 46(32):1618-21. PubMed ID: 5512832
    [No Abstract]   [Full Text] [Related]  

  • 16. [Congenital defects of lipid metabolism. Effect of clofibrate on the level of blood lipids].
    Sobra J
    Cas Lek Cesk; 1969 Nov; 108(48):1439-46. PubMed ID: 4901245
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma lipid and lipoprotein content in chronic ischemic heart disease depending on patients' personality trends].
    Bel'chenko DI; Lazarev VI
    Ter Arkh; 1982; 54(10):55-7. PubMed ID: 7179121
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of regular exercise on lipid and lipoprotein profile in men.
    Yalaz G; Kayatekin BM; Guvel H; Derman S; Gonenc S; Acikgoz O; Semin I
    Indian J Physiol Pharmacol; 1999 Oct; 43(4):523-5. PubMed ID: 10776475
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatty acid makeup of different lipid fractions of plasma lipoproteins in persons dying suddenly from coronary heart disease].
    Aptekar' SG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):36-42. PubMed ID: 7259866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of the range of "clinical norm" for indices of the lipid composition of the blood].
    Lipovetskiĭ BM; Shestov DB; Nikul'cheva NG; Plavinskaia SI
    Klin Med (Mosk); 1982 Sep; 60(9):73-7. PubMed ID: 7176494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.